Lynx1 Capital Management LP Diversified Active

CIK: 0001910456 · Show all filings

Period: Q1 2025 (← Previous) (Next →)

Filing Date: May 15, 2025

Total Value ($000): $279,235 (100.0% shares, 0.0% debt)

Holdings (14)

GHRS GH RESEARCH PLC 25.5%

Value ($000) $71,077 Shares 6,443,940 Est. Cost $9.57 Unrealized +16.9%

— MERUS N V 23.6%

Value ($000) $66,033 Shares 1,568,841 Est. Cost $36.34 Unrealized —

PTGX PROTAGONIST THERAPEUTICS INC 12.7%

Value ($000) $35,449 Shares 733,014 Est. Cost $41.90 Unrealized 0.0%

STOK STOKE THERAPEUTICS INC 12.6%

Value ($000) $35,191 Shares 5,291,929 Est. Cost $7.96 Unrealized +17.1%

CGEM CULLINAN THERAPEUTICS INC 8.7%

Value ($000) $24,343 Shares 3,215,722 Est. Cost $12.31 Unrealized -22.1%

ALLO ALLOGENE THERAPEUTICS INC 5.8%

Value ($000) $16,143 Shares 11,057,009 Est. Cost $2.63 Unrealized -28.2%

CCCC C4 THERAPEUTICS INC 4.1%

Value ($000) $11,357 Shares 7,098,133 Est. Cost $4.48 Unrealized -33.4%

TCRX TSCAN THERAPEUTICS INC 2.6%

Value ($000) $7,393 Shares 5,357,347 Est. Cost $2.72 Unrealized -20.6%

DTIL PRECISION BIOSCIENCES INC 1.3%

Value ($000) $3,654 Shares 766,051 Est. Cost $7.30 Unrealized -30.3%

IBIO IBIO INC 1.2%

Value ($000) $3,466 Shares 862,279 Est. Cost $1.77 Unrealized +119.1%

— PASSAGE BIO INC 1.2%

Value ($000) $3,269 Shares 9,256,953 Est. Cost $1.03 Unrealized —

UPB UPSTREAM BIO INC 0.5%

Value ($000) $1,342 Shares 219,247 Est. Cost $22.33 Unrealized -57.2%

NEUP NEUPHORIA THERAPEUTICS INC 0.1%

Value ($000) $264 Shares 45,806 Est. Cost $3.53 Unrealized +32.3%

DSGN DESIGN THERAPEUTICS INC 0.1%

Value ($000) $255 Shares 65,954 Est. Cost $4.77 Unrealized 0.0%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
GHRS	GH RESEARCH PLC	6,443,940	$71,077	25.5%	$9.57	+16.9%	ORDINARY SHARES	G3855L106
—	MERUS N V	1,568,841	$66,033	23.6%	$36.34	—	COM	N5749R100
PTGX	PROTAGONIST THERAPEUTICS INC	733,014	$35,449	12.7%	$41.90	0.0%	COM	74366E102
STOK	STOKE THERAPEUTICS INC	5,291,929	$35,191	12.6%	$7.96	+17.1%	COM	86150R107
CGEM	CULLINAN THERAPEUTICS INC	3,215,722	$24,343	8.7%	$12.31	-22.1%	COM	230031106
ALLO	ALLOGENE THERAPEUTICS INC	11,057,009	$16,143	5.8%	$2.63	-28.2%	COM	019770106
CCCC	C4 THERAPEUTICS INC	7,098,133	$11,357	4.1%	$4.48	-33.4%	COM STK	12529R107
TCRX	TSCAN THERAPEUTICS INC	5,357,347	$7,393	2.6%	$2.72	-20.6%	COM	89854M101
DTIL	PRECISION BIOSCIENCES INC	766,051	$3,654	1.3%	$7.30	-30.3%	COM NEW	74019P207
IBIO	IBIO INC	862,279	$3,466	1.2%	$1.77	+119.1%	CON NEW	451033708
—	PASSAGE BIO INC	9,256,953	$3,269	1.2%	$1.03	—	COM	702712100
UPB	UPSTREAM BIO INC	219,247	$1,342	0.5%	$22.33	-57.2%	COM	91678A107
NEUP	NEUPHORIA THERAPEUTICS INC	45,806	$264	0.1%	$3.53	+32.3%	COM	64136E102
DSGN	DESIGN THERAPEUTICS INC	65,954	$255	0.1%	$4.77	0.0%	COM	25056L103